PROTHENA CORP PUBLIC LTD CO
Public company- Headquarters
- DUBLIN 2
- Ticker
- PRTA
- CIK
- 0001559053
WARN notices since 2024
1
First: Jun 2, 2025
Workers affected since 2024
91
Across 1 notice
Executive changes, last 12 months
1
0 appointments, 1 departure
Last event
Oct 2, 2026
Executive departureChief Development Officer departs: Chad J. Swanson, Ph.D.
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Chief Development OfficerChad J. Swanson, Ph.D. | Oct 2, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- NOVO NORDISK A S
WARN notice: Plainsboro, NJ
- TEVA PHARMACEUTICAL INDUSTRIES LTD
WARN notice: Fairfield, NJ
- NOVARTIS AG
WARN notice: East Hanover, NJ
- IMMUNIC, INC.
member of the Board of Directors departs: Duane Nash
- Executive departure
Chief Development Officer departs: Chad J. Swanson, Ph.D.
Chad J. Swanson, Ph.D., Chief Development Officer of PROTHENA CORP PUBLIC LTD CO, resigns the role, effective October 9, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 2, 2026Role: Chief Development Officer
Last verified Nov 8, 2026